A66.8
Latent yaws
Clinical Classification Guidelines
Inclusion Terms
- Yaws without clinical manifestations, with positive serology
Medical Intelligence & Overview
Latent yaws is a form of yaws that presents without visible symptoms but is detectable through serological tests. Yaws is a chronic bacterial infection caused by *Treponema pallidum pertenue*, primarily affecting the skin, bones, and cartilage. In the latent stage, individuals do not exhibit the characteristic skin lesions or other evident signs of the disease, making diagnosis based heavily on laboratory testing. Recognizing latent yaws is essential for controlling the spread of this infectious disease and preventing progression to more severe stages.
Causes & Symptoms
Clinical Causes: Infection with *Treponema pallidum pertenue*, typically transmitted through skin-to-skin contact with an infected person. Poor hygiene and living conditions that facilitate close contact with infected individuals. Exposure in endemic regions where yaws remains prevalent, especially among children and communities with limited access to healthcare.
Key Symptoms: Absence of visible skin lesions or ulcers commonly seen in active yaws. Positive serology indicating a previous or current infection, despite the lack of symptoms. Potential for latent phase to persist for months or years if untreated.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of latent yaws relies on serological testing to detect antibodies against *Treponema pallidum pertenue*. Tests such as the non-treponemal (e.g., VDRL, RPR) and treponemal (e.g., FTA-ABS, TPPA) assays are used. A positive serological test combined with the absence of clinical symptoms confirms latent yaws. It's important for healthcare providers to differentiate yaws from other treponemal infections and consider epidemiological context.
Treatment Protocols: Treatment typically involves administration of antibiotics, with penicillin being the first-line therapy. The goal is to eliminate the infection and prevent progression to active yaws or further transmission. The specific dosage and duration depend on age, weight, and health status. Follow-up serology is often conducted to confirm treatment success, and public health measures may include epidemiological surveys and community treatment initiatives.
Clinical Advice & FAQs
Billing Guidance
Is A66.8 a billable ICD-10 code?
Yes, A66.8 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report A66.8?
Clinical documentation must specify the nature of Latent yaws and any associated comorbidities for accurate reporting.
Cite this Clinical Reference